La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Proto Labs Bilan de santé
Santé financière contrôle des critères 6/6
Proto Labs possède un total de capitaux propres de $685.2M et une dette totale de $0.0, ce qui porte son ratio d'endettement à 0%. Son actif total et son passif total sont $758.2M et de $73.0M. L'EBIT de Proto Labs est $31.7M ce qui fait que son ratio de couverture des intérêts -10.6. Elle dispose de liquidités et de placements à court terme de $112.9M.
Informations clés
0%
Ratio d'endettement
US$0
Dette
| Ratio de couverture des intérêts | -10.6x |
| Argent liquide | US$112.94m |
| Fonds propres | US$685.24m |
| Total du passif | US$72.97m |
| Total des actifs | US$758.21m |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Here's What's Concerning About Proto Labs' (NYSE:PRLB) Returns On Capital
Sep 08
Proto Labs: Defensive Strategy Not Paying Off Yet
Aug 13Calculating The Intrinsic Value Of Proto Labs, Inc. (NYSE:PRLB)
Jul 18Proto Labs: Interesting Crossroads
May 28Proto Labs' (NYSE:PRLB) Solid Earnings Are Supported By Other Strong Factors
May 11Proto Labs, Inc.'s (NYSE:PRLB) Price In Tune With Revenues
Apr 13Proto Labs: Cash Flows Are Supporting The Stock
Mar 04Proto Labs: Excellent Business Feats Yet To Financially Materialize
Feb 16Proto Labs (NYSE:PRLB) May Have Issues Allocating Its Capital
Jan 03Proto Labs: Overlooked Digital Manufacturing Opportunity
Dec 04Proto Labs Remains Profitable Despite So Much Pessimism
Sep 25Proto Labs: The Rally Appears Overdone
Jul 14Be Wary Of Proto Labs (NYSE:PRLB) And Its Returns On Capital
Jul 13Is There An Opportunity With Proto Labs, Inc.'s (NYSE:PRLB) 41% Undervaluation?
May 06Proto Labs (NYSE:PRLB) Might Be Having Difficulty Using Its Capital Effectively
Apr 08Proto Labs Non-GAAP EPS of $0.26 beats by $0.05, revenue of $115.6M beats by $5.47M
Feb 10Proto Labs: Transitioning From A Fast Grower To A Slow Grower
Jan 20Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital
Dec 21Proto Labs Q3 2022 Earnings Preview
Nov 03Proto Labs: Improvement Of The Digital Model And Undervalued
Oct 27Is It Too Late To Consider Buying Proto Labs, Inc. (NYSE:PRLB)?
Sep 12Protolabs names new technology chief
Sep 08Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital
Aug 05Proto Labs Q2 2022 Earnings Preview
Aug 04Proto Labs: Not A Great Prospect Until Profitability Issues Clear Up
Jul 07Is Proto Labs, Inc. (NYSE:PRLB) Potentially Undervalued?
May 24Proto Labs (NYSE:PRLB) Could Be Struggling To Allocate Capital
Mar 30The Prognosis For Proto Labs
Feb 22Returns On Capital At Proto Labs (NYSE:PRLB) Paint A Concerning Picture
Nov 28Is There Now An Opportunity In Proto Labs, Inc. (NYSE:PRLB)?
Nov 10Proto Labs: A Play On Additive Manufacturing
Nov 04Investors Could Be Concerned With Proto Labs' (NYSE:PRLB) Returns On Capital
Aug 29Some Investors May Be Willing To Look Past Proto Labs' (NYSE:PRLB) Soft Earnings
Aug 14Estimating The Fair Value Of Proto Labs, Inc. (NYSE:PRLB)
Aug 04Proto Labs: Bringing E-Commerce To Manufacturing
Jul 19What Is Proto Labs, Inc.'s (NYSE:PRLB) Share Price Doing?
Jun 08Proto Labs (NYSE:PRLB) May Have Issues Allocating Its Capital
May 06Proto Labs Q1 2021 Earnings Preview
May 05Analyse de la situation financière
Passif à court terme: Les actifs à court terme de PRLB ( $207.6M ) dépassent ses passifs à court terme ( $50.9M ).
Passif à long terme: Les actifs à court terme de PRLB ( $207.6M ) dépassent ses passifs à long terme ( $22.0M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: PRLB est sans dette.
Réduire la dette: PRLB n'avait aucune dette il y a 5 ans.
Couverture de la dette: PRLB n'a pas de dette, elle n'a donc pas besoin d'être couverte par le flux de trésorerie opérationnel.
Couverture des intérêts: PRLB n'a aucune dette, par conséquent la couverture des paiements d'intérêts n'est pas un problème.